HALEOS LABS LIMITED
HALEOSLABS · Defence · NSE
₹1,423
Current Market Price
Fair Value (DCF)
₹1,629
Discount to FV
+14.5%
Updated just now
YieldIQ Score
55/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
37%
ROE
8.1%
Debt/Equity
0.52
WACC
11.1%
Market Cap
₹430.24 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
14.5%
Return on capital employed
EV / EBITDA
12.3×
Enterprise multiple
Debt / EBITDA
2.5×
Leverage vs earnings
Interest Coverage
4.1×
EBIT covers interest
Current Ratio
1.06×
Short-term liquidity
Asset Turnover
0.86×
Revenue per ₹ of assets
Revenue CAGR (3Y)
2.2%
3-year revenue growth
Revenue CAGR (5Y)
4.7%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,423.1
Bear case
Margin of Safety -87.6%
Implied upside -46.7%
Base case
Margin of Safety +11.2%
Implied upside +12.7%
Bull case
Margin of Safety +26.0%
Implied upside +35.2%
Ratio Trends
HALEOSLABS · last 9 annual periods
ROE
8.1%
ROCE
14.5%
Operating Margin
—
Debt / Equity
0.52×
PE
—
EV / EBITDA
—
Historical Financials
HALEOSLABS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹347 Cr | ₹313 Cr | ₹300 Cr | ₹345 Cr | ₹334 Cr | -1.0% |
| EBITDA | ₹48.4 Cr | ₹33.8 Cr | ₹34.7 Cr | ₹49.9 Cr | ₹47.1 Cr | -0.7% |
| EBIT | ₹38.9 Cr | ₹23.4 Cr | ₹20.0 Cr | — | — | -15.3% |
| PAT | ₹25.3 Cr | ₹11.5 Cr | ₹9.1 Cr | ₹20.1 Cr | ₹17.3 Cr | -9.1% |
| EPS (diluted) | ₹83.68 | ₹37.92 | ₹30.08 | — | — | -22.6% |
| CFO | ₹-11.2 Cr | ₹14.7 Cr | ₹24.3 Cr | ₹34.1 Cr | ₹37.2 Cr | — |
| CapEx | ₹-51.2 Cr | ₹-48.6 Cr | ₹-20.9 Cr | ₹-15.3 Cr | ₹-57.9 Cr | — |
| FCF | ₹-62.4 Cr | ₹-33.9 Cr | ₹3.4 Cr | ₹18.7 Cr | ₹-20.6 Cr | — |
| Total Assets | ₹357 Cr | ₹395 Cr | ₹391 Cr | ₹390 Cr | ₹454 Cr | +6.2% |
| Total Debt | ₹79.6 Cr | ₹100 Cr | ₹101 Cr | ₹86.4 Cr | ₹111 Cr | +8.6% |
| Shareholders' Equity | ₹152 Cr | ₹169 Cr | ₹177 Cr | ₹197 Cr | ₹214 Cr | +8.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
HALEOSLABS vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 LYKALABS LYKALABS | — | — | Pending | -10.9% | — |
 TAKE TAKE | — | — | Pending | — | — |
BALAXI BALAXI | — | — | Pending | 0.6% | 61.1× |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for HALEOSLABS in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HALEOS LABS LIMITED (HALEOSLABS.NS) trades at 1423.10 vs a model fair value of 1629.47, a gap of 14.5%. Piotroski F-score: 4/9. Moat labe...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HALEOSLABS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HALEOSLABS →
Compare
Head-to-head with peers
Compare HALEOSLABS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HALEOSLABSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.